Breast implant infections after surgical reconstruction in patients with breast cancer: Assessment of risk factors and pathogens over extended post-operative observation

Surgical Infections

Volumn 13, Issue 3, 2012, Pages 154-158

  Franchelli, Simonetta ^a   Vassallo, Francesca ^a   Porzio, Claudia ^a   Mannucci, Matilde ^a   Priano, Virginia ^a   Schenone, Eva ^a   Leone, Maria Stella ^a   Canavese, Giuseppe ^a   Santi, Pierluigi ^a,b   De Maria, Andrea ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BREAST CANCER; BREAST IMPLANT INFECTION; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; CONTROLLED STUDY; DEVICE REMOVAL; ENTEROBACTER CLOACAE; ERYTHEMA; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HOSPITAL DISCHARGE; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MASTECTOMY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIMODALITY CANCER THERAPY; OUTPATIENT; PAIN; PATHOGENESIS; PERFORATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS INFECTION; PSEUDOMONAS AERUGINOSA; PUS; RISK ASSESSMENT; SEROMA; SERRATIA MARCESCENS; SKIN PERFORATION; STREPTOCOCCUS AGALACTIAE; SWELLING; WOUND DEHISCENCE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BACTERIA; BREAST IMPLANTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAMMAPLASTY; MIDDLE AGED; POSTOPERATIVE CARE; PROSTHESIS-RELATED INFECTIONS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 84862860850     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.004     Document Type: Article

References (17)

1. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005;5:94-106. (Pubitemid 40174780)
2. Lanier ST, Wang ED, Chen JJ, et al. The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann Plast Surg 2010;64:674-678.
3. Armstrong RW, Bolding E. Infection following breast reconstruction. Ann Plast Surg 1991;27:284-288. (Pubitemid 19242621)
4. Nahabedian M, Tsangaris T, Momen B, Manson P. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003;112:467-476. (Pubitemid 36951436)
5. Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, Faucher A. Complications analysis of 266 immediate breast reconstruction. J Plast Reconstr Aesth Surg 2006;59:1017-1024. (Pubitemid 44391157)
6. Gabriel SE, Woods E, O'Fallon WM, et al. Complications leading to surgery after breast implantation. N Engl J Med 1997;336:677-682. (Pubitemid 27102681)
7. Ahn C, Ko C, Wagar E, et al. Microbial evaluation: 139 implants removed from symptomatic patients. Plast Reconstr Surg 1996;98:1225-1229. (Pubitemid 26406096)
8. Macadam S, Mehling B, Fanning A, et al. Non-tuberculous mycobacterial breast implant infections. Plast Reconstr Surg 2007;1419:337-344. (Pubitemid 46360283)
9. Rahav G, Pillik S, Amitai Z, et al. An outbreak of Mycobacterium jacuzzii infection following insertion of breast implants. Clin Infect Dis 2006;43:823-830. (Pubitemid 44435507)
10. Pegues D, Shireley L, Riddle C, et al. Serratia marcescens surgical wound infection fol1owing breast reconstruction. Am J Med 1991;91:173S-178S.
11. Penel N, Yazdanpanah Y, Chauvet MP, et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol 2007;96:124-129.
12. Bunn F, Cunningham ME, Handscomb K. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. Cochrane Systematic Rev J 2006:CD005360.pub2.
13. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard. CLSI document M02-A10 (ISBN 1-56238-688-3). Tenth edition. Wayne, PA. The Institute. 2009.
14. Vilar-Compte D, Roldan-Marin R, Robles-Vidal C, Volkow P. Surgical site infection (SSI) rates among patients who underwent mastectomy after the introduction of 551 prevention policies. Infect Control Hosp Epidemiol 2006;27:829-834. (Pubitemid 44320334)
15. Olsen MA, Chu-Ongsakul S, Brandt KE, et al. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg 2008;143:53-60. (Pubitemid 351159291)
16. Mangram AJ, Horan TC, Pearson ML, et al. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-278.
17. Tsuji E, Hiki N, Nomura S, et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003;107:303-308. (Pubitemid 37152915)